Your browser doesn't support javascript.
loading
Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models.
Kaweesa, Elizabeth N; Bazioli, Jaqueline M; Pierre, Herma C; Lantvit, Daniel D; Kulp, Samuel K; Hill, Kasey L; Phelps, Mitch A; Coss, Christopher C; Fuchs, James R; Pearce, Cedric J; Oberlies, Nicholas H; Burdette, Joanna E.
Afiliação
  • Kaweesa EN; Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60607, United States.
  • Bazioli JM; Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60607, United States.
  • Pierre HC; Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States.
  • Lantvit DD; Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60607, United States.
  • Kulp SK; Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, Ohio 43210, United States.
  • Hill KL; Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States.
  • Phelps MA; Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States.
  • Coss CC; Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States.
  • Fuchs JR; Division of Medicinal Chemistry and Pharmacognosy, The Ohio State University, Columbus, Ohio 43210, United States.
  • Pearce CJ; Mycosynthetix, Inc., Hillsborough, North Carolina 27278, United States.
  • Oberlies NH; Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States.
  • Burdette JE; Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60607, United States.
Mol Pharm ; 20(6): 3049-3059, 2023 06 05.
Article em En | MEDLINE | ID: mdl-37155928

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Revista: Mol Pharm Assunto da revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Revista: Mol Pharm Assunto da revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos